Substance / Medication

Meropenem

Overview

Active Ingredient
meropenem
RxNorm CUI
29561
Labeler: WG Critical Care, LLCUpdated: 2026-01-08T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Meropenem for injection is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta (β)-lactams.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

24 trials linked to this intervention

24
Total Trials
8
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Pharmacokinetics of ceftriaxone, gentamicin, meropenem and vancomycin in liver cirrhosis: a systematic review.
Comce M H, Weersink R A, Beuers U et al. · J Antimicrob Chemother · 2024
PMID: 39289819Meta-AnalysisFull text (PMC)
Prevalence of meropenem-resistant Pseudomonas Aeruginosa in Ethiopia: a systematic review and meta‑analysis.
Gobezie Mengistie Yirsaw, Hassen Minimize, Tesfaye Nuhamin Alemayehu et al. · Antimicrob Resist Infect Control · 2024
PMID: 38600535Meta-AnalysisFull text (PMC)
Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations.
Charoensareerat Taniya, Chaijamorn Weerachai, Kerdnimith Pathakorn et al. · Blood Purif · 2023
PMID: 37231811Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Meropenem (substance)
SNOMED CT
387540000
UMLS CUI
C0066005
RxNorm CUI
29561
Labeler
WG Critical Care, LLC

Clinical Data

This intervention maps to 14 entities in the Healos knowledge graph.

14
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
24
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.